匯頂科技(603160.SH):明確2021年第一期員工持股計劃購買回購股票的價格及計劃規模
格隆匯6月9日丨匯頂科技(603160.SH)公佈,根據回購計劃截至目前的實際情況以及公司《2021年第一期員工持股計劃(草案)》等相關規定,公司確認2021年第一期員工持股計劃購買標的股票的價格為60.15元/股。此次員工持股計劃可購買公司股票的數量為不超過306.1253萬股,參與對象認購總金額為不超過184,134,367.95元。此次員工持股計劃實際購買公司股票的數量及認購金額根據員工參與該計劃的資金規模最終確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.